Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05117879
Other study ID # 202008004RINC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date September 1, 2025

Study information

Verified date November 2020
Source National Taiwan University Hospital
Contact Li-Chun Chang, PhD
Phone 02-23123456
Email lichunchang@ntu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Colorectal cancer is the most prevalent cancer and the third cancer related death in Taiwan. Adenoma is a precancerous lesion of colorectal cancer. Using colonoscopy to detect and remove the adenoma has a chance to prevent colorectal cancer development. In the resection of colorectal polyps, for medium and large polyps that are more than one centimeter and less than two centimeters, because these polyps are at risk of cancer, they currently use hot-snaring polypectomy or more advanced endoscopic mucosal resection. Resection of such tumors ensures that a sufficient depth of resection and a high complete resection rate (R0 resection) are achieved. Flat serrated adenoma (sessile serrated lesion) is a special adenoma that accounts for 10-12% of all colorectal polyps. Different from traditional adenomas, flat serrated adenomas within two centimeters in size have very little chance of becoming cancerous. And we know that on removal of medium and large polyps of 10-20mm, compared with the cold snaring polypectomy, the postoperative bleeding of the hot-snaring polypectomy technique is higher. Therefore, when removing low-risk polyps such as flat serrated adenomas, we may choose using a non-energized technique with low complications and we then would like to know whether the complete resection rate can be achieved by using the non-energized technique in the resection of a flat serrated adenoma of 10-20 mm, despite the large size, and compare the success rate and complications with traditional hot snaring polypectomy.


Description:

This study is a single-country, multi-center, randomized controlled study. The subjects of the case were patients who underwent colonoscopy for various indications and found flat serrated adenomas ranging in size from 10-20 mm during the procedure. Excluded criterias are patients who are younger than 20 years old and have contraindications for colonoscopy. All patients included in the study will sign the informed consent sheet at the outpatient clinic. Once a flat serrated adenoma with a size of 10-20 mm is found during colonoscopy, the subjects will be randomly assigned to Cold snaring polypectomy group, cold endoscopic mucosal resection group or hot endoscopic mucosal resection group. The preoperative preparation for bowel cleansing and colonoscope insertion method for these three groups of patients are totally the same as those of general colonoscopy. The only difference is the resection method flat serrated glands of 10-20 mm. The tumor was resected by cold snaring polypectomy, one group was resected by cold endoscopic mucosal resection, and the other group was resected by hot endoscopic mucosal resection. The endoscopists participating in this research project have extensive experience in endoscopy and perform at least one hundred polypectomy operations every year. The excised tumor will be sent to the pathology department for pathological diagnosis, and the pathology doctor will judge the completeness of the tumor resection


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date September 1, 2025
Est. primary completion date September 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: 1. Age older than 20 years old 2. Indicated for colonoscopy and willing to receive colonoscopy examination and polyp resection? 3. Any Sessile serrated adenoma size between 10-20mm was found during the examination? Exclusion Criteria: 1. Age younger than 20 years old 2. Contraindication for colonoscopy or polypectomy (Such as recent acute myocardial infarction, pulmonary embolism ,coagulopathy..)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Cold snaring polypectomy/ Cold EMR/Hot EMR
Cold snaring polypectomy: The technique of cold snare polypectomy is used to remove [small colonic polyps] without diathermy, which implies that a polyp is transected by a snare along with a rim of surrounding normal mucosa. Cold EMR: Cold EMR technique comprising submucosal injection of succinylated gelatin and dilute methylene blue before piecemeal cold snare resection of target polyp with a margin of normal tissue. Hot EMR: Hot EMR technique comprising submucosal injection of succinylated gelatin and dilute methylene blue before piecemeal electrocautery snare resection of target polyp with a margin of normal tissue.

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei Taiwan (roc)

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary R0 resection rate The margin of the resected specimen showed no adenoma involvement within 14 days
Secondary Delayed post-polypectomy bleeding Bleeding occurs delayed from several hours to weeks after the polypectomy within 14 days
Secondary Immediate post-polypectomy bleeding Bleeding occur immediately after the polypectomy within 24 hours
Secondary Bowel perforation rate Bowel perforation occurs after colonoscopy within 14 days
Secondary Number of hemoclips per polypectomy Total number of hemoclips used after each polypectomy for hemostasis within 1 hour
Secondary Emergency department visit Patient visit ER after polypectomy for any complication within 14 days
Secondary Procedure time Total time spent for polypectomy and hemostasis technique within 1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT04674306 - Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer Early Phase 1
Active, not recruiting NCT03189576 - Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases N/A
Completed NCT03093207 - Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis Phase 2/Phase 3
Active, not recruiting NCT02389517 - Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant Phase 2
Not yet recruiting NCT06134375 - A Study of Tetrathiomolybdate (TM) Plus Capecitabine Phase 1/Phase 2
Recruiting NCT03945721 - A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients Phase 1
Active, not recruiting NCT03384914 - Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer Phase 2